Abstract:Background Individuals with Parkinson's Disease (PD) commonly have reduced exercise capacity, which impacts autonomy and quality of life. The 6-minute walk test (6MWT) has adequate measurement properties to assess exercise capacity in this population. However, these individuals have a reduced fatigue threshold, which may make it difficult to apply prolonged exercise tests. Two-minute walk test (2MWT) is a potential alternative to optimize the measurement of this outcome. Objectives To assess the t validity of the 2MWT for assessing exercise capacity in individuals with PD. Methods A methodological study was developed. People with idiopathic PD, age ≥ 50 years, medically stable for at least 6 months, classified between the stages 1-3 of the modified Hoehn and Yahr scale were included. Individuals were instructed to walk the longest possible distance in six minutes in a 30-meter corridor. Standardized stimuli were provided every minute of the test. In the second and sixth minutes, the distances covered were recorded. Two tests were performed with an interval of 30 minutes or until hemodynamic stabilization. The best total distance covered (in meters) was used in the analyses. Descriptive statistics was used to characterize the sample. Pearson's Correlation Coefficient was used to investigate the correlation between the tests (6MWT and 2MWT). Regression analysis was used to develop an equation to predict the distance covered in the 6MWT based on the 2MWT. The intraclass correlation coefficient (ICC) was used to assess the validity of the equation. The magnitude of the correlation was classified as follows: very low≤ 0.25; low=0.26-0.49; moderate=0.50-0.69; high = 0.70-0.89; and very high = 0.90-1.00. The significance level was α=0.05. Results Forty-six individuals, 32 males (69.6%), mean age 66.93±8.34 years, and mean disease duration 8.5±5.96 years were included. Most were classified at stage 2.0 (54 .3%) and 3.0 (17.4%) on the modified Hoehn & Yahr Scale. Significant, and very high magnitude correlation between the distance covered in the tests was found (6MWT and 2MWT) (r=0.95; p < 0.001). The equation developed to estimate the distance covered in the 6MWT explained 91% of the 6MWT variability: 6MWTdistance=46,31+(2,40x2MWTdistance). Significant, and very high magnitude agreement between the distance covered in the 6MWT and predicted by the equation was found (ICC= 0.90; p < 0.001). Conclusion Preliminary results indicate adequate validity of the 2MWT to assess exercise capacity in individuals with PD. Furthermore, the developed equation was adequate to predict the distance covered in the 6MWT based upon in the distance covered in the 2MWT. However, the study must be completed to ensure the results. Implications The 2MWT has potential to assess exercise capacity in individuals with PD, and the developed equation can estimate the distance covered in the 6MWT. This can optimize the measurement of this result, making the measurement feasible.

Unsophisticated assessment of the cardiopulmonary function in patients with pectus excavatum using the six minute walk test

Quantitative Evaluation of Cardiopulmonary Functional Reserve in Treated Patients with Pulmonary Embolism

Usefulness of the 6-minute walk test vs cardiopulmonary exercise test for exercise prescription in coronary artery disease patients going into a phase III cardiac rehabilitation program

Is the six-minute walk test still reliable compared to cardiopulmonary exercise test for exercise capacity in children with congenital heart disease?

(F)utility of preoperative pulmonary function testing in pectus excavatum to assess severity

Relationship between six-minute walk distance and cardiopulmonary exercise testing in non-obstructive hypertrophic cardiomyopathy

Taking a walk on the heart failure side: comparison of metabolic variables during walking and maximal exertion

Six-Minute Walking Test in Patients with Chronic Obstructive Pulmonary Disease

What is the effect of peripheral muscle fatigue, pulmonary function, and body composition on functional exercise capacity in acromegalic patients?

Comparison of distance covered, physiological cost, and perceived exertion in four six-minute walk test protocols

SUBMAXIMAL FIELD WALKING TESTS APPLIED IN THE CARDIOPULMONARY ASSESSMENT OF CHILDREN WITH CONGENITAL HEART DISEASE: A SYSTEMATIC REVIEW

Exercise capacity prior to major cancer surgery: A cross‐sectional observational study of the validity of the 6‐minute walk and 30‐second sit‐to‐stand tests

Simplified risk stratification based on cardiopulmonary exercise test: A Spanish two‐center experience

Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis

Validity of estimated aortic pulse wave velocity measured during the 6-min walk test to predict anaerobic fitness before major non-cardiac surgery

Identifying COPD patients with poor health status and low exercise tolerance through the five-repetition sit-to-stand test and modified Medical Research Council Dyspnea Score

Exploring Functional Improvements by Sex in Six-Minute Walk Test, Exertional Angina, and Dyspnea After Enhanced External Counterpulsation Therapy

Cardiac Magnetic Resonance Imaging with Myocardial Strain Assessment Correlates with Cardiopulmonary Exercise Testing in Patients with Pectus Excavatum

Feasibility of the Six-Minute Walk Test for Patients Who Have Cystic Fibrosis, Are Ambulatory, and Require Mechanical Ventilation Before Lung Transplantation

VALIDITY OF THE 2-MINUTE WALK TEST TO ASSESS EXERCISE CAPACITY IN INDIVIDUALS WITH PARKINSON DISEASE

Validation of the two-minute step test in obese with comorbibities and morbidly obese patients